1. The Effectiveness of Digital Insomnia Treatment with Adjunctive Wearable Technology: A Pilot Randomized Controlled Trial
- Author
-
Nathaniel S. Marshall, Delwyn J. Bartlett, Nick Glozier, Melissa Aji, Rafael A. Calvo, Ronald R. Grunstein, Christopher J. Gordon, and David P. White
- Subjects
SEVERITY INDEX ,medicine.medical_specialty ,IMPACT ,Clinical Neurology ,Neuroscience (miscellaneous) ,WEIGHT-LOSS ,Medicine (miscellaneous) ,Wearable computer ,Pilot Projects ,law.invention ,Pittsburgh Sleep Quality Index ,Wearable Electronic Devices ,Randomized controlled trial ,law ,Sleep Initiation and Maintenance Disorders ,medicine ,Clinical endpoint ,Insomnia ,Humans ,COGNITIVE-BEHAVIORAL THERAPY ,Wearable technology ,Psychiatry ,Science & Technology ,Neurology & Neurosurgery ,business.industry ,1103 Clinical Sciences ,Treatment Outcome ,1701 Psychology ,Physical therapy ,Sleep diary ,Neurosciences & Neurology ,Neurology (clinical) ,Psychology (miscellaneous) ,Sleep (system call) ,medicine.symptom ,Sleep ,business ,Life Sciences & Biomedicine ,INTERVENTION - Abstract
Objective This pilot trial aimed to provide evidence for whether the integration of a wearable device with digital behavioral therapy for insomnia (dBTi) improves treatment outcomes and engagement. Participants and methods One hundred and twenty-eight participants with insomnia symptoms were randomized to a 3-week dBTi program (SleepFix®) with a wearable device enabling sleep data synchronization (dBTi+wearable group; n = 62) or dBTi alone (n = 66). Participants completed the Insomnia Severity Index (ISI) and modified Pittsburgh Sleep Quality Index (PSQI) parameters: wake-after-sleep-onset (WASO), sleep-onset-latency (SOL), and total sleep time (TST) at baseline and weeks 1, 2, 3, and primary endpoint of week 6 and follow-up at 12 weeks. Engagement was measured by the number of daily sleep diaries logged in the app. Results There was no difference in ISI change scores between the groups from pre- to post-treatment (Cohen's d= 0.7, p= .061). The dBTi+wearable group showed greater improvements in WASO (d= 0.8, p = .005) and TST (d= 0.3, p= .049) compared to the dBTi group. Significantly greater engagement (sleep diary entries) was observed in the dBTi+wearable group (mean = 22.4, SD = 10.0) compared to the dBTi group (mean = 14.1, SD = 14.2) (p = .010). Conclusions This pilot trial found that integration of wearable device with a digital insomnia therapy enhanced user engagement and led to improvements in sleep parameters compared to dBTi alone. These findings suggest that adjunctive wearable technologies may improve digital insomnia therapy effectiveness.
- Published
- 2021